Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kappa-selective agonists decrease postsynaptic potentials and calcium components of action potentials in the

K Inenaga1, T Nagatomo, K Nakao

  • 1Department of Physiology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.

Neuroscience
|January 1, 1994
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuroprotective mechanism of bromocriptine.

Lancet (London, England)·1995
Same author

Serum 7 alpha-hydroxycholesterol as a new parameter of liver function in patients with chronic liver diseases.

Hepatology (Baltimore, Md.)·1995
Same author

Recurrent cervical abscess due to piriform sinus fistula.

The Journal of laryngology and otology·1995
Same author

Force-velocity relations of rat cardiac myosin isozymes sliding on algal cell actin cables in vitro.

Biochimica et biophysica acta·1995
Same author

Cloning and characterization of a human type II receptor for bone morphogenetic proteins.

Proceedings of the National Academy of Sciences of the United States of America·1995
Same author

Enhanced expression of transforming growth factor-beta and its type-I and type-II receptors in human glioblastoma.

International journal of cancer·1995

Endogenous kappa-receptor agonists, dynorphin and leumorphin, inhibit supraoptic nucleus neurons by suppressing synaptic activity and calcium action potential components. These findings highlight kappa-receptor involvement in neurosecretory cell regulation.

Area of Science:

  • Neuroscience
  • Neuroendocrinology
  • Pharmacology

Background:

  • The supraoptic nucleus (SON) in the rat hypothalamus plays a crucial role in regulating neuroendocrine functions, particularly hormone release.
  • Kappa-opioid receptors are implicated in various physiological processes, but their specific role in SON neurons requires further elucidation.

Purpose of the Study:

  • To investigate the effects of endogenous kappa-receptor agonists, dynorphin and leumorphin, on the electrophysiological properties of SON neurons.
  • To determine the involvement of kappa-opioid receptors in modulating synaptic transmission and action potential characteristics within the SON.

Main Methods:

  • Intracellular recordings were performed on 62 SON neurons in rat hypothalamic slice preparations.
  • Electrophysiological effects of dynorphin, leumorphin, and synthetic kappa-agonist U-50,488H were assessed, along with antagonist MR-2266.

Related Experiment Videos

  • Modulation of postsynaptic potentials and action potential duration, influenced by calcium channel blockers, was analyzed.

    • Main Results:

    • Dynorphin and leumorphin significantly decreased SON neuron firing rate and action potential duration, with minimal membrane hyperpolarization.
    • These inhibitory effects were reversed by the kappa-antagonist MR-2266, confirming kappa-receptor mediation.
    • Dynorphin and leumorphin suppressed evoked postsynaptic potentials and reduced calcium-dependent action potential components.

    Conclusions:

    • Endogenous kappa-receptor agonists exert inhibitory control over neurosecretory cells in the SON.
    • Kappa-receptor activation suppresses synaptic events and voltage-dependent calcium influx in SON neurons.
    • These findings suggest a role for kappa-opioid signaling in regulating SON neuronal activity and neuroendocrine output.